Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
The Affiliated Hospital of Hangzhou Normal University
Age
18–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Meets the Rome IV diagnostic criteria for Irritable Bowel Syndrome (IBS);
Has discontinued IBS-related medications for more than 2 weeks prior to enrollment;
Aged between 18 and 75 years (inclusive);
Has sufficient cognitive ability to provide informed consent, understand study instructions, and complete questionnaires.
You may not be if
Has contraindications to MRI (e.g., metal implants in the body, claustrophobia) or TMS (e.g., history of epilepsy, skull defects);
Diagnosed with mental illnesses (e.g., schizophrenia, bipolar disorder) that require ongoing medication or psychotherapy;
Women who are pregnant, breastfeeding, or planning to become pregnant during the study period;
Presents signs of severe illness requiring hospitalization (e.g., hemodynamic instability, acute infection, acute myocardial infarction, cerebral infarction);
Has taken any substances that may affect study indicators (e.g., probiotics, prebiotics) within 3 months prior to enrollment.
Clareo Health | Study on Treatment Mechanisms and Efficacy Prediction of Individualized Transcranial Magnetic Stimulation in Adults With Irritable Bowel Syndrome Using Multimodal MRI and High-Throughput Sequencing
